Acta Vet. Brno 2020, 89: 115-123

https://doi.org/10.2754/avb202089020115

Prevalence of equine herpesvirus 2 (EHV-2) in equine ocular disease

Šárka Krisová1, Katarína Tóthová1, Dobromila Molinková2, Zita Makra3, Aikaterini M. Zisopoulou1

1University of Veterinary and Pharmaceutical Sciences Brno, Faculty of Veterinary Medicine, Department of Equine Surgery and Diagnostic Imaging, Brno, Czech Republic
2University of Veterinary and Pharmaceutical Sciences Brno, Faculty of Veterinary Medicine, Department of Infectious Diseases and Microbiology, Brno, Czech Republic
3University of Veterinary Science Budapest, Department and Clinic of Equine Medicine, Budapest, Hungary

Received July 23, 2019
Accepted April 30, 2020

References

1. Bell SA, Balasuriya UB, Gardner IA, Barry PA, Wilson WD, Ferraro GL, MacLachlan NJ 2006a: Temporal detection of equine herpesvirus infections of a cohort of mares and their foals. Vet Microbiol 116: 249-257 <https://doi.org/10.1016/j.vetmic.2006.05.002>
2. Bell SA, Balasuriya UB, Nordhausen RW, MacLachlan NJ 2006b: Isolation of equine herpesvirus-5 from blood mononuclear cells of a gelding. J Vet Diagn Invest 18: 472-475 <https://doi.org/10.1177/104063870601800509>
3. Brooks DE, Matthews A, Clode AB 2017: Diseases of the cornea. In: John Wiley & Sons Inc: Equine Ophthalmology. Golden Aspen Drive, Iowa, pp. 252-368
4. Collinson PN, O’Rielly JL, Ficorilli N, Studdert MJ 1994: Isolation of equine herpesvirus type 2 (equine gammaherpesvirus 2) from foals with keratoconjunctivitis. J Am Vet Med Assoc 205: 329-331
5. Fortier G, Van Erck E, Pronost S, Lekeux P, Thiry E 2010: Equine gammaherpesviruses: pathogenesis, epidemiology and diagnosis. Vet J 186: 148-156 <https://doi.org/10.1016/j.tvjl.2009.08.017>
6. Franchini M, Akens M, Bracher V, V Fellenberg R 1997: Characterisation of gamma herpesviruses in the horse by PCR. Virol J 238: 8-13 <https://doi.org/10.1006/viro.1997.8825>
7. Gnann JW, Barton NH, Whitley RJ 1983: Acyclovir: mechanism of action, pharmacokinetics, safety and clinical applications. Pharmacotherapy 3: 275-283 <https://doi.org/10.1002/j.1875-9114.1983.tb03274.x>
8. Gonzalez Medina S 2015: The role of equine herpesviruses in ocular disease: An incidental finding or a pathogen? Equine Vet Educ 27: 623-626 <https://doi.org/10.1111/eve.12501>
9. Hartley CA, Dynon KJ, Mekuria ZH, El-Hage CM, Holloway SA, Gilkerson JR 2013: Equine gammaherpesviruses: Perfect parasites? Vet Microbiol 167: 86-92 <https://doi.org/10.1016/j.vetmic.2013.05.031>
10. Henninger RW, Reed SM, Saville WJ, Allen GP, Hass GF, Kohn CW, Sofaly C 2007: Outbreak of neurologic disease caused by equine herpesvirus‐1 at a University Equestrian Center. J Vet Intern Med 21: 157-165 <https://doi.org/10.1111/j.1939-1676.2007.tb02942.x>
11. Hollingsworth SR, Pusterla N, Kass PH, Good KL, Brault SA, Maggs DJ 2015: Detection of equine herpesvirus in horses with idiopathic keratoconjunctivitis and comparison of three sampling techniques. Vet Ophthalmol 18: 416-421 <https://doi.org/10.1111/vop.12250>
12. Hue ES, Fortier GD, Fortier CI, Leon AM, Richard EA, Legrand LJ, Pronost SL 2014: Detection and quantitation of equid gammaherpesviruses (EHV-2, EHV-5) in nasal swabs using an accredited standardised quantitative PCR method. J Virol 198: 18-25
13. Kershaw O, Von Oppen T, Glitz F, Deegen E, Ludwig H, Borchers K. 2001: Detection of equine herpesvirus type 2 (EHV-2) in horses with keratoconjunctivitis. Virus Res 80: 93-99 <https://doi.org/10.1016/S0168-1702(01)00299-4>
14. Muscat KE, Padalino B, Hartley CA, Ficorilli N, Celi P, Knight P, Raidal S, Gilkerson JR, Muscatello G 2018: Equine transport and changes in equid herpesvirus’ status. Front Vet Sci 5: 224 <https://doi.org/10.3389/fvets.2018.00224>
15. Nordengrahn A, Merza M, Ros C, Lindholm A, Pálfi V, Hannant D, Belák S 2002: Prevalence of equine herpesvirus types 2 and 5 in horse populations by using type-specific PCR assays. Vet Res 33: 251-259 <https://doi.org/10.1051/vetres:2002013>
16. Rushton JO, Kolodziejek J, Tichy A, Nell B, Nowotny N 2013a: Detection of equid herpesviruses 2 and 5 in a herd of 266 Lipizzaners in association with ocular findings. Vet Microbiol 164: 139-144 <https://doi.org/10.1016/j.vetmic.2013.01.035>
17. Rushton JO, Kolodziejek J, Tichy A, Nowotny N, Nell B 2013b: Clinical course of ophthalmic findings and potential influence factors of herpesvirus infections: 18 month follow-up of a closed herd of lipizzaners. PloS one 8: e79888 <https://doi.org/10.1371/journal.pone.0079888>
18. Rushton JO, Kolodziejek J, Nell B, Weissenböck H, Nowotny N 2016: Keratoconjunctivitis in a group of Icelandic horses with suspected γ‐herpesvirus involvement. Equine Vet J 48: 427-429 <https://doi.org/10.1111/evj.12465>
19. Seeber PA, Quintard B, Sicks F, Dehnhard M, Greenwood AD, Franz M 2018: Environmental stressors may cause equine herpesvirus reactivation in captive Grévy’s zebras (Equus grevyi). PeerJ 6: e5422 <https://doi.org/10.7717/peerj.5422>
20. Studdert MJ 1996: Equine herpesvirus 2 and disease. Equine Vet J 28: 426-428 <https://doi.org/10.1111/j.2042-3306.1996.tb01612.x>
21. Wilkins PA, Henninger R, Reed SM, Piero FD 2003: Acyclovir as treatment for EHV-1 myeloencephalopathy. Proceedings of the 49th Annual Convention of the American Association of Equine Practitioners: 394-396
22. Wong DM, Maxwell LK, Wilkins PA 2010: Use of antiviral medications against equine herpes virus associated disorders. Equine Vet Educ 22: 244-252 <https://doi.org/10.1111/j.2042-3292.2010.00048.x>
front cover
  • ISSN 0001-7213 (printed)
  • ISSN 1801-7576 (electronic)

Current issue

Archive